Matisse Capital - ORCHARD THERAPEUTICS PLC ownership

ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 74 filers reported holding ORCHARD THERAPEUTICS PLC in Q4 2021. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.

Quarter-by-quarter ownership
Matisse Capital ownership history of ORCHARD THERAPEUTICS PLC
ValueSharesWeighting
Q4 2021$13,000
-59.4%
10,000
-28.6%
0.01%
-25.0%
Q3 2021$32,000
-47.5%
14,0000.0%0.01%
-36.8%
Q2 2021$61,000
-70.7%
14,000
-51.6%
0.02%
-36.7%
Q1 2021$208,000
+235.5%
28,900
+100.0%
0.03%
+57.9%
Q4 2020$62,000
+6.9%
14,450
+3.2%
0.02%
-17.4%
Q3 2020$58,000
-79.9%
14,000
-63.4%
0.02%
-79.6%
Q1 2020$288,000
-43.4%
38,275
+3.4%
0.11%
-68.7%
Q4 2019$509,00037,0000.36%
Other shareholders
ORCHARD THERAPEUTICS PLC shareholders Q4 2021
NameSharesValueWeighting ↓
CHI Advisors LLC 6,449,856$8,514,0002.83%
RA Capital Management 9,694,789$12,797,0000.23%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,949,416$9,173,0000.19%
HARBOR CAPITAL ADVISORS, INC. 275,870$364,0000.13%
Artal Group S.A. 1,803,858$2,381,0000.06%
GSA CAPITAL PARTNERS LLP 338,756$447,0000.06%
PLATINUM INVESTMENT MANAGEMENT LTD 1,335,174$1,762,0000.05%
PVG ASSET MANAGEMENT CORP 10,000$13,200,0000.05%
Anson Funds Management LP 348,266$460,0000.04%
Eversept Partners, LP 419,581$553,8470.04%
View complete list of ORCHARD THERAPEUTICS PLC shareholders